Pharmaceuticals

Counterfeiting Drives Change Counterfeit medicines, such as rogue batches of the blood thinning drug Heparin sold in 2008, are known to have killed dozens of patients. In the absence of tough global regulation, leading pharmaceutical ingredients suppliers are introducing a new generation of quality-control systems and vendor qualification programs to combat the problem. Concern with the pharmaceutical supply chain is “the highest it has ever been,” says Guy Villax, head of Hovione (Loures, Portugal), and a board member of the European Fine Chemicals...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers